Buscogast Injection 1 ml Ampoule

babies: not applicable. lactating mother: it is safe to use this medicine during breastfeeding.
long term use of this medication may reduce milk secretion. human studies suggest that this medicine does not pass into breast milk, and it does not cause any risk to the baby.
pregnancy: it is unsafe to use this medicine during pregnancy. seek doctors advice before taking this medication.
alcohol: you should avoid alcohol consumption as it may lead to excessive sleepiness. driving: hyoscine butyl bromide injection is not safe while driving as it may affect your vision. kidney: hyoscine butyl bromide should be used with caution in patients with kidney disease.
dose adjustment should be made. liver: consult your doctor before taking this medicine because it should be used with caution in patients with liver disease..

Dry mouth Blurred vision Diarrhea Sever allergic reactions Fast heart rate Dilation of pupil.

BUSCOGAST injection is anticholinergic. it works by reducing contractions and by relaxing smooth muscles in the stomach and intestine.
eventually, it leads to decrease pain and discomforts..

Please consult your doctor immediately if you have reaction to BUSCOGAST.

• you need to inform your doctor if you are pregnant or intend to be pregnant and breastfeeding • drink plenty of water to prevent dehydration • hyoscine butyl bromide injection should be given under medical supervision • avoid driving after taking this because it may cause dizziness and sleepiness • you should avoid alcohol consumption as it may lead to excessive sleepiness • eat fibre rich foods and maintain a healthy weight.

• hyoscine butyl bromide +acetazolamide: concurrent use may increase central system activities of hyoscine butyl bromide. • hyoscine butyl bromide +aclidinium: concurrent use may lead to an increase in the risk of adverse effects.
• hyoscine butyl bromide +cisapride: concurrent use may result in loss of cisapride efficacy. • hyoscine butyl bromide +potassium: concurrent use may result in the risk of gastrointestinal lesions.
• hyoscine butyl bromide + amantidine: concurrent use may result in potentiation of anticholinergic effects. • hyoscine butyl bromide +zolpidem: concurrent use may result in an increased risk of drowsiness, dizziness, and disorientation.
• hyoscine butyl bromide+ stramonium may increase the risk of adverse cns reactions, intestinal obstruction and urinary retention. • hyoscine butyl bromide + buspirone: concurrent use may result in an increased risk of drowsiness, dizziness and disorientation.
• hyoscine butyl bromide + biperiden: concurrent use may increase the risk of cns adverse reactions, intestinal obstruction and urinary retention. • hyoscine butyl bromide + atropine: concurrent use may increase the risk of cns adverse reactions, intestinal obstruction and urinary retention.
.